BCL2 and ovarian carcinoma: c-myc, cyclin D, BCL2, and caspase-3 are the targets of Wnt pathway, c-myc has been showed to regulate ovarian cancer cisplatin resistance, cyclin D is associated with cell proliferation23, BCL2 and caspase-3 are apoptosis inhibitors24.